Target Price | $49.22 |
Price | $24.13 |
Potential |
103.99%
register free of charge
|
Number of Estimates | 9 |
9 Analysts have issued a price target Pieris Pharmaceuticals, Inc. 2026 .
The average Pieris Pharmaceuticals, Inc. target price is $49.22.
This is
103.99%
register free of charge
$70.00
190.10%
register free of charge
$38.00
57.48%
register free of charge
|
|
A rating was issued by 9 analysts: 9 Analysts recommend Pieris Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Pieris Pharmaceuticals, Inc. stock has an average upside potential 2026 of
103.99%
register free of charge
|
Analyst | Rating | Action | Date |
---|---|---|---|
Canaccord Genuity |
Locked
➜
Locked
|
Locked | May 16 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Chardan Capital |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
Stifel |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
Jones Trading |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
Scotiabank |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
Analyst Rating | Date |
---|---|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
May 16 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Chardan Capital:
Locked
➜
Locked
|
Apr 09 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
Locked
Stifel:
Locked
➜
Locked
|
Mar 26 2025 |
Locked
Jones Trading:
Locked
➜
Locked
|
Mar 25 2025 |
Locked
Scotiabank:
Locked
➜
Locked
|
Mar 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.